Gary S. Gilkeson Career Development Award Grant
Funding Amount
Up to US $140,000
Deadline
Deadline not published
Grant Type
Foundation
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Eligible organizations
- Be a clinical fellow (any year) or up to two years post-clinical fellowship in an adult or childhood fellowship program in rheumatology, nephrology, or dermatology that is accredited by either the American Council on Graduate Medical Education (in the U.S.) or the Royal College of Physicians and…
Geography
- Be a citizen or legal resident of the U.S. or Canada at the time of application.
Other requirements
- Hold an MD or PhD (or equivalent) from an accredited institution.
Not eligible / not funded
- Not eligible: Eligibility is for those with relevant degrees and experience in lupus-related research, excluding prior recipients of certain awards.
- Not eligible: Applicants who currently receive or have previously been awarded any of the following awards (or similar) are ineligible to apply:A mentored award (such as a K award) or NIH research grant (such as an RO1, RO3, R21, PO1, P50, or any similar award)American College of Rheumatology (ACR) Rheumatology…
Overview
The Gary S. Gilkeson Career Development Award, offered by the Lupus Foundation of America, supports the professional growth of fellows and clinicians in nephrology, rheumatology, and dermatology focused on lupus research. It provides up to $140,000 over two years, with $70,000 awarded in the first year. Eligibility is for those with relevant degrees and experience in lupus-related research, excluding prior recipients of certain awards. This initiative aims to advance lupus investigation in the U.S. and Canada.
The Lupus Foundation of America’s Gary S. Gilkeson Career Development Award facilitates the professional development of current fellows (any year), clinicians up to two years post- fellowship and/or within four years of postdoctoral research in nephrology, rheumatology, or dermatology, in the U.S. or Canada. Their work should focus on the investigation of basic, clinical, translational, behavioral, or epidemiological lupus research.
Funding Opportunity
The Gary S. Gilkeson Career Development Award will provide four grant awards of up to $140,000.00 each over the two-year grant period. Grants will be awarded based on the availability of funds, and will be paid to the applicant’s institution. Awardees’ institutions will receive $70,000.00 for the first year of the grant. After the first year, funding may be renewed for a second year for up to $70,000.00. Renewal of grant funding is dependent upon the grantees’ progress toward their project goals, and submission of a lupus-specific abstract based on the LFA-funded research.
Eligibility
Hold an MD or PhD (or equivalent) from an accredited institutionBe a citizen or legal resident of the U.S. or Canada at the time of applicationBe a clinical fellow (any year) or up to two years post-clinical fellowship in an adult or childhood fellowship program in rheumatology, nephrology, or dermatology that is accredited by either the American Council on Graduate Medical Education (in the U.S.) or the Royal College of Physicians and Surgeons (in Canada) with documented history of conducting lupus research or;Be a postdoctoral fellow doing lupus-related research with ≥ 2 years and ≤ 4 years of mentored, non-independent research training experience after the terminal non-medical doctorate at the time of application
Ineligibility
Applicants who currently receive or have previously been awarded any of the following awards (or similar) are ineligible to apply:A mentored award (such as a K award) or NIH research grant (such as an RO1, RO3, R21, PO1, P50, or any similar award)American College of Rheumatology (ACR) Rheumatology Research Foundation (RRF)Rheumatology Scientist Development AwardACR RRF Rheumatology Investigator AwardACR RRF Career Development Bridge Funding AwardVeteran’s Administration Career Development Award
What Lupus Foundation of America Inc actually gave
Source: IRS Form 990, 2025
- Grants in 2025
- 5
- Total given
- $380K
- Median grant
- $45K
- Range
- $9,874–$140K
- By dollars: Washington 37%, Massachusetts 37%, Maryland 12%. Top recipient cities: Seattle, WA; Somerville, MA; Baltimore, MD.
- 0% of grants with a stated purpose were for general or operating support.
Example grants
Seattle Children's Hospital · Seattle, WA
Research
$140K
Massachusetts General · Somerville, MA
Research
$140K
Johns Hopkins Univerisity · Baltimore, MD
Research
$45K
Duke University · Durham, NC
Research
$45K
The Regents of the University of California San Francisco · San Francisco, CA
Research
$9,874
Focus Areas & Funding Uses
Fields of Work
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
DoW Military Burn, Technology/Therapeutic Development Award
Defense Health Agency Contracting Activity - DHACA
Amount
$5,000,000 total
Deadline
October 21, 2026
Parkinson's Disease Therapeutics Pipeline Grant Program
The Michael J Fox Foundation for Parkinson's Research
Amount
US $250,000 - US $2,000,000
Deadline
October 30, 2026
Listed date — confirm with the funder
DoW Military Burn, Patient-Centered Research Award
Defense Health Agency Contracting Activity - DHACA
Amount
$3,400,000 total
Deadline
October 21, 2026
DoW Military Burn, Discovery Award
Defense Health Agency Contracting Activity - DHACA
Amount
$400,000 total
Deadline
October 21, 2026
DoW Tick-Borne Disease Therapeutic/Diagnostic Research Award
Defense Health Agency Contracting Activity - DHACA
Amount
$2,650,000 total
Deadline
October 22, 2026
DoW Arthritis Clinical Research Award
Defense Health Agency Contracting Activity - DHACA
Amount
$7,150,000 total
Deadline
October 22, 2026
Ready to apply for Gary S. Gilkeson Career Development Award Grant?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Gary S. Gilkeson Career Development Award Grant. Now let's win it.